Want to join the conversation?
$MDXG reported a 31% jump in 3Q16 revenue driven by strong growth in the commercial side of its wound care business, despite vacations impact. Revenue grew to $64.4MM from $49MM last year. With many year-end deductibles being met during 4Q16, $MDXG expects typical additive impact on 4Q revenue. $MDXG plans to release 3Q results on Oct. 27, 2016.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?